Silencing MARCH2 Inhibits the Invasion, Migration, and EMT Transformation of Human Colorectal Cancer SW480 Cells

Yun Liu1, Ran Longyan2, Qingxi Guo1

  • 1Department of Pathology, 556508Affiliated Hospital of Southwest Medical University, Luzhou, China.

Insights

High expression of membrane-associated RING-CH2 (MARCH2) is linked to colorectal cancer (CRC) progression and poor survival. Silencing MARCH2 inhibits CRC cell invasion and metastasis, suggesting MARCH2 is a potential biomarker for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) is a major global health concern.
  • Understanding the molecular mechanisms driving CRC progression, invasion, and metastasis is crucial for developing effective treatments.
  • The role of membrane-associated RING-CH2 (MARCH2) in CRC remains to be fully elucidated.

Purpose of the Study:

  • To investigate the role of MARCH2 in the progression, invasion, and migration of colorectal cancer (CRC).
  • To determine the correlation between MARCH2 expression and clinicopathological features and survival in CRC patients.
  • To explore the underlying molecular mechanisms involving epithelial-mesenchymal transition (EMT).

Main Methods:

  • Retrospective analysis of MARCH2 and E-cadherin expression in CRC tissues using immunohistochemistry.
  • In vitro experiments involving MARCH2 gene silencing in SW480 CRC cells using siRNA.
  • Assessment of cell invasion and migration using Transwell and Scratch assays.
  • Quantitative real-time PCR (qRT-PCR) and Western blotting to analyze EMT markers.

Main Results:

  • MARCH2 was significantly overexpressed in CRC tissues compared to adjacent tissues.
  • High MARCH2 expression correlated with larger tumor size, advanced pathological grade, lymph node metastasis, and shorter survival time.
  • MARCH2 silencing reduced CRC cell invasion and migration, upregulated E-cadherin, and downregulated Vimentin, indicating inhibition of EMT.

Conclusions:

  • Elevated MARCH2 expression is associated with unfavorable prognosis in CRC patients.
  • MARCH2 may serve as an independent prognostic biomarker for CRC.
  • MARCH2 promotes CRC invasion and metastasis, potentially through the regulation of EMT.

Related Concept Videos

Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K